Search Results - "Lapret, I"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    S62798, a TAFIa inhibitor, accelerates endogenous thrombolysis in a murine model of pulmonary thromboembolism

    S62798, a TAFIa inhibitor, accelerates endogenous thrombolysis in a murine model of pulmonary thromboembolism by Sansilvestri-Morel, P, Bertin, F, Lapret, I, Neau, B, Blanc-Guillemaud, V, Petit-Dop, F, Tupinon-Mathieu, I, Delerive, P

    Published in European heart journal (01-11-2020)
    “…Abstract   Pulmonary embolism (PE) is the third leading cause of cardiovascular death in western countries. The enhancement of fibrinolysis constitutes a…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    P340Vascular contractile responses to alpha1-adrenergic agonists along the aorta and their control by nitric oxide

    P340Vascular contractile responses to alpha1-adrenergic agonists along the aorta and their control by nitric oxide by Simonet, S, Juchet-Martin, M, Lapret, I, Bernhardt, F, Diguet, N, Courchay, C, Bourguignon, M-P, Villeneuve, N

    Published in Cardiovascular research (01-04-2018)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    REDUCED NO BIOAVAILABILITY, OXIDATIVE STRESS AND ALTERATION OF CALCIUM HOMEOSTASIS IN VASCULAR ENDOTHELIUM FROM DIABETIC MICE

    REDUCED NO BIOAVAILABILITY, OXIDATIVE STRESS AND ALTERATION OF CALCIUM HOMEOSTASIS IN VASCULAR ENDOTHELIUM FROM DIABETIC MICE by Banquet, S, Bourguignon, MP, Garry, A, Royere, E, Crespo, C, Lapret, I, Simonet, S, Gosgnach, W, Thollon, C, Villeneuve, N, Vilaine, JP

    Published in The FASEB journal (01-04-2013)
    “…Abstract only Endothelial dysfunction is a major risk factor for vascular complications associated with diabetes. The purpose of this study was to evaluate the…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: